Opko Health OPK Pharmaceutical — Selling General And Administrative Expense

Other segment segments

Similar metrics at other companies

BLCOPharmaceuticals — Selling, general and administrative (Note 4)

$138M-9.8%

BAXPharmaceuticals — Selling, general and administrative expenses

$102M-1.0%

VRTXPharmaceuticals — Selling and other commercial expenses

$313.6M+30.1%

ABTEstablished Pharmaceuticals — Selling, general, and administrative

$376M+7.1%

BTSGPharmacy Solutions — Selling General And Administrative Expense From Reportable

$157.03M+35.7%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

Questions, answered.

What is Opko Health's pharmaceutical — selling general and administrative expense?

Opko Health (OPK) reported pharmaceutical — selling general and administrative expense of $14.21M in Q1 2026.

How has Opko Health's pharmaceutical — selling general and administrative expense changed year-over-year?

Opko Health's pharmaceutical — selling general and administrative expense increased by 11.8% year-over-year, from $12.71M to $14.21M.

What is the long-term trend for Opko Health's pharmaceutical — selling general and administrative expense?

Over 2 years (2023 to 2025), Opko Health's pharmaceutical — selling general and administrative expense has grown at a -1.6% compound annual growth rate (CAGR), from $55.69M to $53.87M.

What does pharmaceutical — selling general and administrative expense mean?

The operating costs incurred by the pharmaceutical segment for administrative support, marketing, sales, and general corporate overhead. These expenses represent the fixed and variable costs required to support the segment's commercial operations.